CorMedix Therapeutics | Company Profile, Culture & Jobs

Open positions6 open marketing positions

Sr. Manager, Market Access Marketing

CorMedix Therapeutics

Parsippany, NJ (On-site)

$146K/yr - $201K/yrIn-houseFull-timeSenior level3+ years exp.

1 month ago

Director, Corporate Communications

CorMedix Therapeutics

Parsippany, NJ (Hybrid)

$171K/yr - $210K/yrIn-houseFull-time

2 months ago

Sr. Manager, Market Access Marketing

CorMedix Therapeutics

Parsippany, NJ (On-site)

$146K/yr - $201K/yrIn-houseFull-timeSenior level3+ years exp.

3 months ago

Manager, Marketing - Legacy Products

CorMedix Therapeutics

Parsippany, NJ (On-site)

$112K/yr - $168K/yrIn-houseFull-timeManager4+ years exp.

3 months ago

Sr. Mgr, Hospital & Institutional Marketing

CorMedix Therapeutics

Parsippany, NJ (On-site)

$146K/yr - $201K/yrIn-houseFull-timeSenior level4+ years exp.

3 months ago

Associate Director Corporate Communications

CorMedix Therapeutics

Parsippany, NJ (Hybrid)

$145K/yr - $175K/yrIn-houseFull-time

4 months ago

Similar roles at other companies

Senior Global Product Marketing Manager, Search Ads

TikTok

San Jose, CA (On-site)

$159K/yr - $384K/yrIn-houseFull-timeSenior level

5 hrs ago

Group Narrative Product Marketing Manager, Google Cloud AI

Google

Seattle, WA (On-site)

$219K/yr - $305K/yrIn-houseFull-timeSenior level13+ years exp.

13 hrs ago

Group Narrative Product Marketing Manager, Google Cloud AI

Google

Sunnyvale, CA (On-site)

$219K/yr - $305K/yrIn-houseFull-timeSenior level13+ years exp.

15 hrs ago

Director, Product Marketing - WEM

Genesys

USA (Remote)

$163K/yr - $287K/yrIn-houseFull-timeSenior level

23 hrs ago

Company overview

CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company is focused on developing its lead product DefenCathTM, a novel, antibacterial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. DefenCath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product (QIDP), and the original New Drug Application (NDA) received priority review in recognition of its potential to address an unmet medical need. For more information, visit: www.cormedix.com.

Founded in 2006

Berkeley Heights, New Jersey, USA

180 employees (6 in marketing)

www.cormedix.com

0% recommend to a friend

100% positive business outlook

People

Founders

Matt David, MD

Interim Chief Executive Officer, Chief Financial Officer

Joseph Todisco

Chairman & CEO

Marketing leadership

Hiring activity

Open marketing jobs over time

6 open now

Headcount trend

Company growth over the last 12 months

Funding

Total funding

$96.5M

Last raise

$85M

Post IPO Equity, 12 months ago

Funding history

Jun 2025

Post IPO Equity CorMedix · $85M

Nov 2017

Post IPO Equity CorMedix · $5M

Oct 2013

Post IPO Equity CorMedix · $3M

Oct 2012

Post IPO Debt CorMedix · $850K

Nov 2009

Venture Round CorMedix · $2.6M

Audience

Monthly website visitors

12.4K

Month over month+50.6%

Quarter over quarter+26.5%

Top sourceSearch (46.4%)

Ad budget per month$0.0

Average search rank38.7

Traffic source mix

Search

46.4%

Direct

36.2%

News

CorMedix announces United States Court of Appeals affirms patent judgements

Jun 8, 2026 • TipRanks

Federal Circuit Upholds CorMedix MINOCIN Patent Protection

Jun 8, 2026 • TipRanks

Federal appeals court upholds CorMedix patent win over Nexus By Investing.com

Jun 8, 2026 • Investing.com Canada

Links

www.cormedix.com

Crunchbase

X (Twitter)

Glassdoor

CorMedix Therapeutics insights

Company and marketing-team signals from saved company data and employee profiles. Use this before you apply, interview, or negotiate.

Founded

2006

Headquarters

Berkeley Heights, New Jersey

Employees

11-50

50% growth last 12mo

Marketing team

6

3% of company

13 saved employee profiles are linked to this company.

Overall company growth

Shows if the company is growing, flat, or shrinking.

Growing 50%

LinkedIn headcount is up 50% over the last 12 months.

Company stability and risk

Shows a quick risk view from growth, funding age, and news.

Main result

Low risk

Series C–like · Growing 50% last 12 months · More mature · Recently funded

Trend

2021-06-28 -> 2026-06-29

Headcount (12 months)

+50%

Last funding round

12 months ago

Negative news (120 days)

0

Risk score0/7

Website traffic

Shows traffic size, change, and traffic sources.

Monthly website visitors

12.4K

Month over month+50.6%

Quarter over quarter+26.5%

Top sourceSearch (46.4%)

Traffic source mix

Search

46.4%

Direct

36.2%

Competitors and search

Shows competitors and key search metrics in one view.

Main result

21 competitor sites

Search traffic: 829 organic clicks / 0 paid clicks

Organic competitors

5

Paid competitors

0

Keyword change

-12

Ad budget per month

$0.0

Average search rank

38.7

Organic competitors5

LinkedIn followers

Shows follower count and growth.

LinkedIn followers

Follower count and growth

Total followers

6.3K

12-mo growth

+49.4%

Job openings

Shows open jobs, growth, and role changes.

Main result

9 open jobs

Open jobs trend: +3.5%

Trend

2023-08-01 -> 2026-06-01

Open jobs growth

+3.5%

Biggest role change

sales: 0%

Latest open role

Key Account Manager - San Antonio

Marketing team growth

Shows if the marketing team is growing, flat, or shrinking.

Unknown

We need LinkedIn role growth data for marketing-related functions.

Marketing leader strength

Shows how strong marketing leadership looks at company level.

Low

Marketing leadership appears more mid-level today. Typical leader time at company: 1.2 years.

Founder or CEO

Saved founder and CEO profiles.

Matt David, MD

Interim Chief Executive Officer, Chief Financial Officer

Joseph Todisco

Chairman & CEO

Marketing team size

Shows saved marketing team size.

6

3% of the company • 13 saved marketing people

Hiring manager

Shows saved hiring contacts for this job area.

Beth Steinbrenner

SVP, Chief Human Resources Officer

Mercedes De Vasquez, MBA

HR Business Partner

Marisa Ameen

HR Business Partner

First hire or larger team

Shows if this looks like one hire or a bigger team.

Looks like larger team

Based on saved marketing team size: 6.

Glassdoor ratings

Shows saved Glassdoor ratings.

Glassdoor ratings

Overall rating

4 / 5

Work-life balance

3 / 5

Culture

3 / 5

Diversity & inclusion

3 / 5

Recommend to a friend

0%

Positive business outlook

100%

Funding

Shows saved funding data.

Total funding

$96.5M

Last raise

Post IPO Equity

12 months ago

Funding details

Amount raised

$96.5M

Last round

Post IPO Equity

Last fundraise

12 months ago

News

Shows saved company news.

CorMedix announces United States Court of Appeals affirms patent judgements

Jun 8, 2026 • TipRanks

Federal Circuit Upholds CorMedix MINOCIN Patent Protection

Jun 8, 2026 • TipRanks

Federal appeals court upholds CorMedix patent win over Nexus By Investing.com

Jun 8, 2026 • Investing.com Canada

Marketing leadership

Shows saved marketing leaders.

Jen Becker

Head of Corporate Communications (Fractional)

Kajal Preuss

Sr. Director, Brand Marketing

Matt Balogh

Sr. Director, Digital Marketing & AI Innovation

Loading insights...

Jen Becker

Head of Corporate Communications (Fractional)

Kajal Preuss

Sr. Director, Brand Marketing

Matt Balogh

Sr. Director, Digital Marketing & AI Innovation

David Tapp

Director Brand Management, DefenCath

Hiring contacts

Beth Steinbrenner

SVP, Chief Human Resources Officer

Mercedes De Vasquez, MBA

HR Business Partner

Marisa Ameen

HR Business Partner

Headcount +50% year over year

Social

10%

Referral

6%

Paid referral

1.2%

LinkedIn followers

Follower count and growth

Total followers

6.3K

12-mo growth

+49.4%

Monthly growth

+8.6%

Salaries

Typical salary range

$146,000 – $201,000

/ yr

Help build salary transparency at CorMedix Therapeutics

Share your compensation anonymously to see full data.

Contribute

CorMedix Therapeutics insights

Company and marketing-team signals from saved company data and employee profiles. Use this before you apply, interview, or negotiate.

Founded

2006

Headquarters

Berkeley Heights, New Jersey

Employees

11-50

50% growth last 12mo

Marketing team

6

3% of company

13 saved employee profiles are linked to this company.

Overall company growth

Shows if the company is growing, flat, or shrinking.

Growing 50%

LinkedIn headcount is up 50% over the last 12 months.

Company stability and risk

Shows a quick risk view from growth, funding age, and news.

Main result

Low risk

Series C–like · Growing 50% last 12 months · More mature · Recently funded

Trend

2021-06-28 -> 2026-06-29

Headcount (12 months)

+50%

Last funding round

12 months ago

Negative news (120 days)

0

Risk score0/7

Website traffic

Shows traffic size, change, and traffic sources.

Monthly website visitors

12.4K

Month over month+50.6%

Quarter over quarter+26.5%

Top sourceSearch (46.4%)

Traffic source mix

Search

46.4%

Direct

36.2%

Competitors and search

Shows competitors and key search metrics in one view.

Main result

21 competitor sites

Search traffic: 829 organic clicks / 0 paid clicks

Organic competitors

5

Paid competitors

0

Keyword change

-12

Ad budget per month

$0.0

Average search rank

38.7

Organic competitors5

LinkedIn followers

Shows follower count and growth.

LinkedIn followers

Follower count and growth

Total followers

6.3K

12-mo growth

+49.4%

Job openings

Shows open jobs, growth, and role changes.

Main result

9 open jobs

Open jobs trend: +3.5%

Trend

2023-08-01 -> 2026-06-01

Open jobs growth

+3.5%

Biggest role change

sales: 0%

Latest open role

Key Account Manager - San Antonio

Marketing team growth

Shows if the marketing team is growing, flat, or shrinking.

Unknown

We need LinkedIn role growth data for marketing-related functions.

Marketing leader strength

Shows how strong marketing leadership looks at company level.

Low

Marketing leadership appears more mid-level today. Typical leader time at company: 1.2 years.

Founder or CEO

Saved founder and CEO profiles.

Matt David, MD

Interim Chief Executive Officer, Chief Financial Officer

Joseph Todisco

Chairman & CEO

Marketing team size

Shows saved marketing team size.

6

3% of the company • 13 saved marketing people

Hiring manager

Shows saved hiring contacts for this job area.

Beth Steinbrenner

SVP, Chief Human Resources Officer

Mercedes De Vasquez, MBA

HR Business Partner

Marisa Ameen

HR Business Partner

First hire or larger team

Shows if this looks like one hire or a bigger team.

Looks like larger team

Based on saved marketing team size: 6.

Glassdoor ratings

Shows saved Glassdoor ratings.

Glassdoor ratings

Overall rating

4 / 5

Work-life balance

3 / 5

Culture

3 / 5

Diversity & inclusion

3 / 5

Recommend to a friend

0%

Positive business outlook

100%

Funding

Shows saved funding data.

Total funding

$96.5M

Last raise

Post IPO Equity

12 months ago

Funding details

Amount raised

$96.5M

Last round

Post IPO Equity

Last fundraise

12 months ago

News

Shows saved company news.

CorMedix announces United States Court of Appeals affirms patent judgements

Jun 8, 2026 • TipRanks

Federal Circuit Upholds CorMedix MINOCIN Patent Protection

Jun 8, 2026 • TipRanks

Federal appeals court upholds CorMedix patent win over Nexus By Investing.com

Jun 8, 2026 • Investing.com Canada

Marketing leadership

Shows saved marketing leaders.

Jen Becker

Head of Corporate Communications (Fractional)

Kajal Preuss

Sr. Director, Brand Marketing

Matt Balogh

Sr. Director, Digital Marketing & AI Innovation

Social

10%

Referral

6%

Paid referral

1.2%

Monthly growth

+8.6%

David Tapp

Director Brand Management, DefenCath